The role of mesenchymal cells in the pathophysiology of inflammatory arthritis

Best Practice and Research: Clinical Rheumatology

Volumn 20, Issue 5, 2006, Pages 969-981

  Meyer, Lars Henrik ^a   Franssen, Lars ^a   Pap, Thomas ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

activation; apoptosis; attachment; extracellular matrix degradation; Fas; fibroblast like synoviocytes; hyperplasia; matrix metalloproteinases

Indexed keywords

FAS ANTIGEN; INTEGRIN; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL FUNCTION; DISEASE COURSE; DISEASE SEVERITY; FIBROBLAST; HUMAN; HYPERPLASIA; INFLAMMATION; INFLAMMATORY CELL; JOINT DESTRUCTION; MESENCHYMAL STEM CELL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL DISABILITY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM;

ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CYTOKINES; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; HYPERPLASIA; INTEGRINS; MATRIX METALLOPROTEINASES; MESODERM; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748478814     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2006.06.005     Document Type: Review

References (98)

1. Smith R.S., Smith T.J., Blieden T.M., and Phipps R.P. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. The American Journal of Pathology 151 2 (1997) 317-322
2. Takemura S., Klimiuk P.A., Braun A., et al. T cell activation in rheumatoid synovium is B cell dependent. Journal of Immunology 167 (2001) 4710-4718
3. Seibl R., Birchler T., Loeliger S., et al. Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. The American Journal of Pathology 162 4 (2003) 1221-1227
4. Pierer M., Rethage J., Seibl R., et al. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. Journal of Immunology 172 2 (2004) 1256-1265
5. Brentano F., Schorr O., Gay R.E., et al. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis and Rheumatism 52 9 (2005) 2656-2665
6. Haynes B.F., Grover B.J., Whichard L.P., et al. Synovial microenvironment-T cell interactions. Human T cells bind to fibroblast-like synovial cells in vitro. Arthritis and Rheumatism 31 8 (1988) 947-955
7. Salmon M., Scheel-Toellner D., Huissoon A.P., et al. Inhibition of T cell apoptosis in the rheumatoid synovium. The Journal of Clinical Investigation 99 (1997) 439-446
8. Bombara M., Webb D.L., Conrad P., et al. Cell contact between T cells and synovial fibroblasts causes induction of adhesion molecules and cytokines. Journal of Leukocyte Biology 54 5 (1993) 399-406
9. Lindhout E., van Eijk M., van Pel M., et al. Fibroblast-like synoviocytes from rheumatoid arthritis patients have intrinsic properties of follicular dendritic cells. Journal of Immunology 162 (1999) 5949-5956
10. Hamann J., Wishaupt J.O., van Lier R.A., et al. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Arthritis and Rheumatism 42 (1999) 650-658
11. Buckley C.D., Pilling D., Lord J.M., et al. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends in Immunology 22 4 (2001) 199-204
12. Firestein G.S., and Zvaifler N.J. How important are T cells in chronic rheumatoid synovitis?: II. T cell-independent mechanisms from beginning to end. Arthritis and Rheumatism 46 2 (2002) 298-308
13. Pope R.M., and Perlman H. Rheumatoid arthritis. In: Tsokas G.C. (Ed). Principles of Molecular Rheumatology (2000), Humana Press, Totowa, New Jersey 325-361
14. + T-cells in rheumatoid arthritis. European Journal of Immunology 28 (1998) 2661-2671
15. Harada S., Yamamura M., Okamoto H., et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis and Rheumatism 42 7 (1999) 1508-1516
16. Nanki T., Hayashida K., El-Gabalawy H.S., et al. Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. Journal of Immunology 165 11 (2000) 6590-6598
17. Rollins B.J. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Molecular Medicine Today 2 5 (1996) 198-204
18. Iwamoto T., Okamoto H., Iikuni N., et al. Monocyte chemoattractant protein-4 (MCP-4)/CCL13 is highly expressed in cartilage from patients with rheumatoid arthritis. Rheumatology (Oxford) 45 4 (2006) 421-424
19. Sciaky D., Brazer W., Center D.M., et al. Cultured human fibroblasts express constitutive IL-16 mRNA: cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism. Journal of Immunology 164 7 (2000) 3806-3814
20. Pritchard J., Tsui S., Horst N., et al. Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves' disease, express high levels of IL-16 when treated with Igs against insulin-like growth factor-1 receptor. Journal of Immunology 173 5 (2004) 3564-3569
21. Qu Z., Garcia C.H., O'Rourke L.M., et al. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc and nucleolar organizer region staining. Arthritis and Rheumatism 37 2 (1994) 212-220
22. Taniguchi K., Kohsaka H., Inoue N., et al. Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nature Medicine 5 7 (1999) 760-767
23. Mor A., Abramson S.B., and Pillinger M.H. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clinical Immunology 115 2 (2005) 118-128
24. Aicher W.K., Heer A.H., Trabandt A., et al. Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients. Journal of Immunology 152 12 (1994) 5940-5948
25. Mountz J.D., Hsu H.C., Matsuki Y., and Zhang H.G. Apoptosis and rheumatoid arthritis: past, present, and future directions. Current Rheumatology Reports 3 1 (2001) 70-78
26. Perlman H., Georganas C., Pagliari L.J., et al. Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. Journal of Immunology 164 10 (2000) 5227-5235
27. Liu H., and Pope R.M. The role of apoptosis in rheumatoid arthritis. Current Opinion in Pharmacology 3 3 (2003) 317-322
28. Wakisaka S., Suzuki N., Takeba Y., et al. Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA). Clinical and Experimental Immunology 114 1 (1998) 119-128
29. Kurowska M., Rudnicka W., Kontny E., et al. Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-x(L) and Bcl-2. Journal of Immunology 169 4 (2002) 1760-1767
30. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
31. Nakajima T., Aono H., Hasunuma T., et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis and Rheumatism 38 4 (1995) 485-491
32. Pap T., Muller-Ladner U., Gay R.E., and Gay S. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Research 2 (2000) 361-367
33. Hasunuma T., Kayagaki N., Asahara H., et al. Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis. Arthritis and Rheumatism 40 1 (1997) 80-86
34. Takemura Y., Fukuo K., Yasuda O., et al. Fas signaling induces Akt activation and upregulation of endothelial nitric oxide synthase expression. Hypertension 43 4 (2004) 880-884
35. Osaki M., Kase S., Adachi K., et al. Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45. Journal of Cancer Research and Clinical Oncology 130 1 (2004) 8-14
36. Perlman H., Pagliari L.J., Liu H., et al. Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis and Rheumatism 44 1 (2001) 21-30
37. Catrina A.I., Ulfgren A.K., Lindblad S., et al. Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium. Annals of the Rheumatic Diseases 61 10 (2002) 934-936
38. Schedel J., Gay R.E., Kuenzler P., et al. FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis. Arthritis and Rheumatism 46 6 (2002) 1512-1518
39. Irmler M., Thome M., Hahne M., et al. Inhibition of death receptor signals by cellular FLIP. Nature 388 6638 (1997) 190-195
40. Palao G., Santiago B., Galindo M., et al. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis. Arthritis and Rheumatism 50 9 (2004) 2803-2810
41. Melchior F. SUMO-nonclassical ubiquitin. Annual Review of Cell and Developmental Biology 16 (2000) 591-626
42. Okura T., Gong L., Kamitani T., et al. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. Journal of Immunology 157 (1996) 4277-4281
43. Franz J.K., Pap T., Hummel K.M., et al. Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis and Rheumatism 43 (2000) 599-607
44. Ghezzi P., and Cerami A. Tumor necrosis factor as a pharmacological target. Molecular Biotechnology 31 3 (2005) 239-244
45. Reddy S.A.G., Huang J.H., and Liao W.S.L. Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation. Journal of Immunology 164 3 (2000) 1355-1363
46. Keffer J., Probert L., Cazlaris H., et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. The EMBO Journal 10 13 (1991) 4025-4031
47. Chu C.Q., Field M., Feldmann M., and Maini R.N. Localization of tumour necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis and Rheumatism 34 (1991) 1125-1132
48. Feldmann M., Brennan F.M., and Maini R.N. Role of cytokines in rheumatoid arthritis. Annual Review of Immunology 14 (1996) 397-440
49. Hsu H., Shu H.B., Pan M.G., et al. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84 2 (1996) 299-308
50. Madge L.A., and Pober J.S. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells. The Journal of Biological Chemistry 275 20 (2000) 15458-15465
51. Ohshima S., Mima T., Sasai M., et al. Tumour necrosis factor alpha (TNFα) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism ofrheumatoid synovial hyperplasia and a clinical benefit of anti-TNFα therapy for RA. Cytokine 12 3 (2000) 281-288
52. Drynda A., Quax P.H., Neumann M., et al. Gene transfer of tissue inhibitor of metalloproteinases-3 reverses the inhibitory effects of TNFα on Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. Journal of Immunology 174 10 (2005) 6524-6531
53. Sen M. Wnt signalling in rheumatoid arthritis. Rheumatology (Oxford) 44 6 (2005) 708-713
54. Muller-Ladner U., Kriegsmann J., Franklin B.N., et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. The American Journal of Pathology 149 5 (1996) 1607-1615
55. Ospelt C., Neidhart M., Gay R.E., and Gay S. Synovial activation in rheumatoid arthritis. Frontiers in Bioscience 9 (2004) 2323-2334
56. Werner S., and Grose R. Regulation of wound healing by growth factors and cytokines. Physiological Reviews 83 (2003) 835-870
57. Stransky G., Vernon J., Aicher W.K., et al. Virus-like particles in synovial fluids from patients with rheumatoid arthritis. British Journal of Rheumatology 32 12 (1993) 1044-1048
58. Franz J.K., Pap T., Muller-Ladner U., et al. T cell-independent joint destruction. In: Miossec P., van den Berg W.B., and Firestein G.S. (Eds). T cells in arthritis (1998), Birkhäuser Verlag, Basel 55-74
59. el Gabalawy H., and Wilkins J. Beta 1 (CD29) integrin expression in rheumatoid synovial membranes: an immunohistologic study of distribution patterns. The Journal of Rheumatology 20 (1993) 231-237
60. Muller-Ladner U., Elices M.J., Kriegsmann J., et al. Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. The Journal of Rheumatology 24 (1997) 1873-1880
61. Pirila L., Aho H., Roivainen A., et al. Identification of alpha6beta1 integrin positive cells in synovial lining layer as type B synoviocytes. The Journal of Rheumatology 28 (2001) 478-484
62. Rinaldi N., Schwarz E.M., Weis D., et al. Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins. Annals of the Rheumatic Diseases 56 (1997) 45-51
63. Sarkissian M., and Lafyatis R. Integrin engagement regulates proliferation and collagenase expression of rheumatoid synovial fibroblasts. Journal of Immunology 162 (1999) 1772-1779
64. Lin T.H., Chen Q., Howe A., and Juliano R.L. Cell anchorage permits efficient signal transduction between ras and its downstream kinases. Journal of Biological Chemistry 272 (1997) 8849-8852
65. Inoue H., Yamashita A., and Hakura A. Adhesion-dependency of serum-induced p42/44 MAP kinase activation is released by retroviral oncogenes. Virology 225 (1996) 223-226
66. Ravanti L., Heino J., Lopez-Otin C., and Kahari V.M. Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. Journal of Biological Chemistry 274 (1999) 2446-2455
67. Wang A.Z., Wang J.C., Fisher G.W., and Diamond H.S. Interleukin-1beta-stimulated invasion of articular cartilage by rheumatoid synovial fibroblasts is inhibited by antibodies to specific integrin receptors and by collagenase inhibitors. Arthritis and Rheumatism 40 (1997) 1298-1307
68. Mulherin D., Fitzgerald O., and Bresnihan B. Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. British Journal of Rheumatology 35 12 (1996) 1263-1268
69. Kraan M.C., Versendaal H., Jonker M., et al. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis and Rheumatism 41 8 (1998) 1481-1488
70. Brown P.D. Ongoing trials with matrix metalloproteinase inhibitors. Expert Opinion on Investigational Drugs 9 (2000) 2167-2177
71. Muller-Ladner U., Gay R.E., and Gay S. Cysteine proteinases in arthritis and inflammation. Perspect Drug Discovery Design 6 (1996) 87-98
72. Parks W.C., and Mecham R.P. Matrix metalloproteinases (1998), Academic Press, San Diego
73. Nagase H. Activation mechanisms of matrix metalloproteinases. Biological Chemistry 378 (1997) 151-160
74. Pap T., Shigeyama Y., Kuchen S., et al. Differential expression of membrane-type matrix metalloproteinases (MT-MMPs) in rheumatoid arthritis (RA). Arthritis and Rheumatism 43 (2000) 1226-1232
75. Kinne R.W., Boehm S., Iftner T., et al. Synovial fibroblast-like cells strongly express jun-B and C-fos proto-oncogenes in rheumatoid- and osteoarthritis. Scandinavian Journal of Rheumatology Supplement 101 (1995) 121-125
76. Asahara H., Fujisawa K., Kobata T., et al. Direct evidence of high DNA-binding activity of transcription factor AP-1 in rheumatoid arthritis synovium. Arthritis and Rheumatism 40 (1997) 912-918
77. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 423 (2003) 356-361
78. Han Z., Boyle D.L., Manning A.M., and Firestein G.S. AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28 4 (1998) 197-208
79. Han Z., Boyle D.L., Chang L., et al. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. The Journal of Clinical Investigation 108 1 (2001) 73-81
80. Bond M., Fabunmi R.P., Baker A.H., and Newby A.C. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Letters 435 1 (1998) 29-34
81. Bond M., Baker A.H., and Newby A.C. Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts. Biochemical and Biophysical Research Communications 264 2 (1999) 561-567
82. Bondeson J., Brennan F., Foxwell B., and Feldmann M. Effective adenoviral transfer of IkappaBalpha into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines is nuclear factor-kappaB dependent. The Journal of Rheumatology 27 9 (2000) 2078-2089
83. Reunanen N., Li S., Ahonen M., et al. Activation of p38α MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization. Journal of Biological Chemistry 277 35 (2002) 32360-32368
84. Kotlyarov A., and Gaestel M. Is MK2 (mitogen-activated protein kinase-activated protein kinase 2) the key for understanding post-transcriptional regulation of gene expression?. Biochemical Society Transactions 30 (2002) 959-963
85. Vincenti M.P., Coon C.I., Lee O., and Brinckerhoff C.E. Regulation of collagenase gene expression by IL-1 beta requires transcriptional and post-transcriptional mechanisms. Nucleic Acids Research 22 22 (1994) 4818-4827
86. Delany A.M., and Brinckerhoff C.E. Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. Journal of Cellular Biochemistry 50 4 (1992) 400-410
87. Saarialho-Kere U.K., Chang E.S., Welgus H.G., and Parks W.C. Expression of interstitial collagenase, 92-kDa gelatinase, and tissue inhibitor of metalloproteinases-1 in granuloma annulare and necrobiosis lipoidica diabeticorum. Journal of Investigative Dermatology 100 3 (1993) 335-342
88. Brinckerhoff C.E., Plucinska I.M., Sheldon L.A., and O'Connor G.T. Half-life of synovial cell collagenase mRNA is modulated by phorbol myristate acetate but not by all-trans-retinoic acid or dexamethasone. Biochemistry 25 21 (1986) 6378-6384
89. Pei D., and Weiss S.J. Furin-dependent intracellular activation of human stromelysin-3 zymogen. Nature 375 (1995) 244-247
90. Gomez D.E., Alonso D.F., Yoshijji H., and Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. European Journal of Cell Biology 74 (1997) 111-122
91. Brew K., Dinakarpandian D., and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochimica et Biophysica Acta 1477 (2000) 267-283
92. Jackson C.J., Arkell J., and Nguyen M. Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1). Annals of the Rheumatic Diseases 57 3 (1998) 158-161
93. Su S., Grover J., Roughley P.J., et al. Expression of the tissue inhibitors of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints. Rheumatoloy International 18 (1999) 183-191
94. Kraan M.C., Reece R.J., Barg E.C., et al. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers. Arthritis and Rheumatism 43 (2000) 1820-1830
95. Pap T., Muller-Ladner U., Gay R.E., and Gay S. Gene therapy in rheumatoid arthritis: how to target joint destruction?. Arthritis Research 1 (1999) 5-9
96. Greenwald R.A., Golub L.M., Ramamurthy N.S., et al. In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: relationship to bone and cartilage degradation. Bone 22 (1998) 33-38
97. Greenwald R.A. Thirty-six years in the clinic without an MMP inhibitor. What hath collagenase wrought?. Annals of the New York Academy of Sciences 878 (1999) 413-419
98. Joosten L.A., Helsen M.M., Saxne T., et al. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNFα blockade only ameliorates joint inflammation. Journal of Immunology 163 9 (1999) 5049-5055